From: CD1C is associated with breast cancer prognosis and immune infiltrates
Clinicopathological Characteristics | Number | High Expression | Low Expression | P-value |
---|---|---|---|---|
Age (years) | Â | Â | Â | 0.472 |
 ≤55 | 63 | 36 | 27 |  |
 >55 | 42 | 21 | 21 |  |
Grade | Â | Â | Â | 0.045 |
 1 | 22 | 15 | 7 |  |
 2 | 59 | 34 | 25 |  |
 3 | 24 | 8 | 16 |  |
Stage | Â | Â | Â | 0.038 |
 I | 32 | 23 | 9 |  |
 II | 59 | 29 | 30 |  |
 III | 14 | 5 | 9 |  |
T classification | Â | Â | Â | 0.021 |
 T1 | 40 | 28 | 12 |  |
 T2 | 60 | 28 | 32 |  |
 T3 | 5 | 1 | 4 |  |
N classification | Â | Â | Â | 0.233 |
 N0 | 74 | 44 | 30 |  |
 N1 | 20 | 9 | 11 |  |
 N2 | 11 | 4 | 7 |  |
 N3 | 0 | 0 | 0 |  |
M classification | Â | Â | Â | Â |
 M0 | 57 | 48 |  |  |
Subtype | Â | Â | Â | 0.092 |
 Luminal A | 20 | 13 | 7 |  |
 Luminal B | 62 | 31 | 31 |  |
 HER-2 | 13 | 10 | 3 |  |
 basal | 10 | 3 | 7 |  |
ER | Â | Â | Â | 0.47 |
 positive | 80 | 45 | 35 |  |
 negative | 25 | 12 | 13 |  |
PR | Â | Â | Â | 0.793 |
 positive | 80 | 44 | 36 |  |
 negative | 25 | 13 | 12 |  |
HER2 | Â | Â | Â | 0.631 |
 positive | 24 | 12 | 12 |  |
 negative | 81 | 45 | 36 |  |
Ki-67 | Â | Â | Â | 0.425 |
 ≤14 | 28 | 17 | 11 |  |
 >15 | 77 | 40 | 37 |  |
Lymph Node Metastasis | Â | Â | Â | 0.02 |
 positive | 26 | 9 | 17 |  |
 negative | 79 | 48 | 31 |  |